News
4d
Medical Device Network on MSNFinland’s AIATELLA secures funds for AI cardiovascular imaging solutionsFinnish startup AIATELLA has raised €2m ($2.27m) in financing to develop and scale its cardiovascular imaging technology ...
At the meeting, Qiu received the Prince-Meaney Translational Science Award, an honor that is part of the ISMRM Young ...
It is a portable, ultra-low-field magnetic resonance imaging device for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical.
The Global Clinical Trial Imaging Market is expected to grow at a rate of 8% by 2026. Growing number of biotechnology & pharmaceutical firms and Contract Research Organizations (CROs), increasing R&D ...
The global diagnostic imaging market is expected to witness a growth rate of 5-6% during the forecast period. This growth is ...
Iradimed Corporation (NASDAQ: IRMD), a global leader in innovative medical devices for MRI environments, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...
Phys.org on MSN22d
MRI Gets Nano-Sized UpgradeConventional MRI scans, familiar to us from hospitals, have a resolution of around one-tenth of a millimeter, which allows them to image incredibly ...
It is a portable, ultra-low-field magnetic resonance imaging device for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical.
XENOVIEW™, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and ...
Bayer seeks Japanese marketing authorization for low-dose contrast agent, gadoquatrane for contrast-enhanced MRI of all body regions and CNS: Berlin Tuesday, June 3, 2025, 13:00 H ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results